PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$23.10M
Total Shares
16.27M
Net Share Change
-1.10M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Patient Capital Management
$23.10M16.27M shares
TRIM-1.10M(-6.4%)